Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
Selection of the optimal peri- and postprocedural antithrombotic regimen in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is a common clinical problem which may pose a challenge to medical practitioners. This systematic review summarizes the updated evide...
Enregistré dans:
Auteurs principaux: | Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta M. Siller-Matula, Anna Tomaszuk-Kazberuk |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/db48a90338b94bd7b02c1566ce8d177a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
par: Gilda Denise Zielinski, et autres
Publié: (2020) -
Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
par: Pedro Luis Cepas-Guillen, et autres
Publié: (2021) -
Eficacia y seguridad del tratamiento anticoagulante oral con antagonistas de vitamina K en pacientes con prótesis valvulares cardíacas
par: Marín,Arnaldo, et autres
Publié: (2014) -
Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
par: Fuwei Liu, et autres
Publié: (2021) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
par: Turagam MK, et autres
Publié: (2015)